This brand name is authorized in Nigeria.
The drug AMPINE contains one active pharmaceutical ingredient (API):
1
|
UNII
864V2Q084H - AMLODIPINE BESYLATE
|
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
A4-4439 | Tablet | AMPINE 10 TAB 10 mg 1010,214,310 | 13 CMS-PP-324303 AMPINE 10 AMLODIPINE BESYLATE AMLODIPINE BESYLATE 10MG A4-4439 Drugs Nigerian Products 1010,214,310 Prescription Only Medicine (POM) 4/19/2023 ORFEMA PHARMACEUTICAL INDUSTRY LIMITED, 5, ATILADE ADEBOWALE STREET, OFF DADDY SAVAGE ROAD, OFF IJU ROAD 14537852 info@orfema.com ORFEMA PHARMACEUTICAL INDUSTRIES LTD, 5, ATILADE ADEBOWALE STREET, OFF DADDY SAVAGE ROAD, FAGBA IJU AGEGE LAGOS, Nigeria | 21/12/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
C08CA01 | Amlodipine | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | A4-4439 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.